Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Canbay

Showing results (261-270 of 297) with videos related to

Pageof 30
Sort By:
Plos One|September 13, 2016
Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic CholangiopathiesJan Best, Stefaan Verhulst, Wing-Kin Syn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2014
Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failureAlexander Koch, Henning W Zimmermann, Nikolaus Gassler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2015
Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinomaBenjamin Juntermanns, Svenja Sydor, Gernot M Kaiser, et al.
Hepatology Communications|January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysisAyesha Shah, Michael P Jones, Gavin Callaghan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2012
An ex vivo perfusion system emulating in vivo conditions in noncirrhotic and cirrhotic human liverThomas Schreiter, Guido Marquitan, Malin Darnell, et al.
Transplantation|June 14, 2008
Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patientsFuat H Saner, Steven W M Olde Damink, Goran Pavlakovic, et al.
Liver Cancer|December 5, 2019
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 RadioembolizationClemens Schotten, Lars P Bechmann, Paul Manka, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activationAlexander Dechêne, Jan-Peter Sowa, Robert K Gieseler, et al.
Virchows Archiv : an International Journal of Pathology|March 31, 2017
Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panelsJulia Kälsch, Juliet Padden, Stefanie Bertram, et al.
Biochimica Et Biophysica Acta|December 3, 2014
A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumorsHenning Reis, Carolin Pütter, Dominik A Megger, et al.
Pageof 30

Showing results (261-270 of 297) with videos related to

Sort By:
Pageof 30
Plos One|September 13, 2016
Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic CholangiopathiesJan Best, Stefaan Verhulst, Wing-Kin Syn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2014
Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failureAlexander Koch, Henning W Zimmermann, Nikolaus Gassler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2015
Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinomaBenjamin Juntermanns, Svenja Sydor, Gernot M Kaiser, et al.
Hepatology Communications|January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysisAyesha Shah, Michael P Jones, Gavin Callaghan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2012
An ex vivo perfusion system emulating in vivo conditions in noncirrhotic and cirrhotic human liverThomas Schreiter, Guido Marquitan, Malin Darnell, et al.
Transplantation|June 14, 2008
Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patientsFuat H Saner, Steven W M Olde Damink, Goran Pavlakovic, et al.
Liver Cancer|December 5, 2019
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 RadioembolizationClemens Schotten, Lars P Bechmann, Paul Manka, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activationAlexander Dechêne, Jan-Peter Sowa, Robert K Gieseler, et al.
Virchows Archiv : an International Journal of Pathology|March 31, 2017
Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panelsJulia Kälsch, Juliet Padden, Stefanie Bertram, et al.
Biochimica Et Biophysica Acta|December 3, 2014
A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumorsHenning Reis, Carolin Pütter, Dominik A Megger, et al.
Pageof 30